文献速递妇科

妇科癌症治疗后女性抑郁风险持续多年增加:一项随访长达19年的登记队列研究

Increased risk for depression persists for years among women treated for gynecological cancers - a register-based cohort study with up to 19 years of follow-up.
PubMed 文献 · Gynecol Oncol · 2019-04-08

该登记队列研究随访1998至2013年确诊的16833例妇科癌症患者与138888例对照女性,最长19年,发现卵巢癌、子宫内膜癌和宫颈癌患者诊断后1年抗抑郁药使用风险均升高,且持续多年,晚期疾病、教育程度低和合并症与抗抑郁药使用相关。

要点

  • 卵巢癌、子宫内膜癌和宫颈癌患者诊断后1年抗抑郁药使用风险均高于对照女性。
  • 三种癌症的抗抑郁药使用风险升高持续多年,卵巢癌持续最长可达八年。
  • 晚期疾病、教育程度低和合并症与抗抑郁药使用相关。

核心结论

  • 妇科癌症患者与无癌症史女性相比抑郁风险增加,且风险在诊断后多年持续升高,贯穿并超出标准肿瘤随访期。
  • 晚期疾病、教育程度低和合并症是该患者群体中与抗抑郁药使用相关的因素。

研究设计与样本

  • 基于登记资料的队列研究,随访1998至2013年确诊的16833例妇科癌症患者和138888例对照女性,最长随访19年。
  • 分析前排除有严重精神疾病史者及研究入组前三年内已领取抗抑郁药处方者。
  • 采用回归分析比较患者与对照女性抗抑郁药使用风险,并分析社会人口学及临床危险因素与抗抑郁药使用的关联。

主要发现

  • 诊断后1年,卵巢癌患者抗抑郁药使用风险升高(HR 4.14,95%CI 3.74-4.59),子宫内膜癌患者升高(HR 2.19,95%CI 1.97-2.45),宫颈癌患者升高(HR 3.14,95%CI 2.74-3.61)。
  • 三种癌症组抗抑郁药使用风险升高在诊断后持续多年,卵巢癌持续时间最长,可达八年。
  • 晚期疾病与抗抑郁药使用的关联最强,其次为教育程度低和合并症。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Little is known about long-term risk of depression in women treated for gynecological cancers. We aim to investigate risk for depression among these women compared to women without a history of cancer. METHODS: We followed 16,833 women diagnosed with gynecological cancers between 1998 and 2013 and 138,888 reference women in nationwide registers for up to 19 years. Women with a history of severe psychiatric disorders, and those who had redeemed a prescription for antidepressants three years before study entry were excluded from analyses. Regression analyses were applied to compare the risk for antidepressant use among patients compared to reference women, and to investigate associations between socio-demographic as well as clinical risk factors and use of antidepressants. RESULTS: We found an increased risk for antidepressant use among women treated for ovarian (HR 4.14, 95% CI 3.74-4.59), endometrial (HR 2.19, 95% CI 1.97-2.45), and cervical cancer (HR 3.14, 95% CI 2.74-3.61) one year after diagnosis. This increased risk persisted years after diagnosis in all three groups, with the longest (up to eight years) found for ovarian cancer. Advanced disease was strongly associated with antidepressant use followed by short education, and comorbidity. CONCLUSIONS: Women diagnosed with gynecological cancer have an increased risk for depression compared to reference women. The risk remains increased for years after diagnosis throughout and beyond standard oncological follow-up care. Advanced disease, short education, and comorbidity are factors associated with antidepressant use in this patient group.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Horsboel TA, Kjaer SK, Johansen C, et al. Increased risk for depression persists for years among women treated for gynecological cancers - a register-based cohort study with up to 19 years of follow-up. Gynecol Oncol. 2019. PMID: 30975472. doi:10.1016/j.ygyno.2019.03.259

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。